Retrograde Cannulation of the Thoracic Duct and Embolization of the Cisterna Chyli in the Treatment of Chylous Ascites

Mittleider, Derek; Dykes, Thomas A.; Cicuto, K.; Amberson, Steven M.; Leusner, Charles R.

doi:10.1016/j.jvir.2007.10.025

Search citation statements

Order By: Relevance

Paper Sections

Select...

Discussion4

Future Prospects1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2013

2021

Publication Types

Select...

Article7

Book3

Relationship

Self Cite0

Independent10

Authors

Journals

Cited by 80 publications

(59 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Retrograde transvenous access to the thoracic duct was described by Mittleider et al (6) and Koike et al (7). In this technical note, a superselective catheterization of the injured branch of the thoracic duct was performed.…”

Section: Discussionmentioning

confidence: 99%

Superselective retrograde lymphatic duct embolization for management of postoperative lymphatic leak

Arslan

Masrani²,

Tasse³

et al. 2017

Diagn Interv Radiol

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Superselective retrograde lymphatic duct embolization for management of postoperative lymphatic leak

Arslan

Masrani²,

Tasse³

et al. 2017

Diagn Interv Radiol

View full text Add to dashboard Cite

“…To recall, the former technique of thoracic duct cannulation has had its day [22]. Nowadays, the new technique of intravital videomicroscopy has appeared [23].…”

Section: Discussionmentioning

confidence: 99%

Can Translational Medicine Exploit the Reported "Metastatic Inefficiency" of Lung Cancer Spreading to the Liver?

Onuigbo¹

2016

Transl Med

View full text Add to dashboard Cite

In the early 1950s, 2 scientists considered the making of progress in cancer research. One of them was Arnott, a Harveian Orator, who promoted the view that, if the metastatic pattern appears to be anomalous, it is a pointer to the direction to take in remedial researching. Another giant was Professor Cameron, who delivered a Memorial Lecture on the liver which is now enmeshed in the anomaly viewed as "metastatic inefficiency." As he posited, hypotheses should be formulated to explain such matters even if the outcome seems hopeless. As regards the liver itself, I had illustrated the anomalous patterns and offered an explanation based on the spatial distribution of its discrete secondary deposits. This time, the emphasis is on careful case reports because they graphically confirm the formulated theoretical concepts. As a follow-up, the effective role of the newly named "Erythrocyte Associated Necrosis Factor" (EANF) has been entertained. In all probability, if adequate searchlight is beamed on EANF through the well funded field of translational medicine, breakthroughs ought to arise as regards target therapy. Moreover, this could conduce to cancer cure sooner than later.

show abstract

“…It is probable that duct embolization in this case was performed too high so that the actual leak was not treated. The patient was subsequently treated with peritovenous shunt surgery [2,7].…”

Section: Discussionmentioning

confidence: 99%

Successful Minimally Invasive Treatment of Intractable, Postoperative Chylous Ascites Via Percutaneous Lymph Vessel Embolization

Pieper

Schild

2015

Cardiovasc Intervent Radiol

View full text Add to dashboard Cite

Retrograde Cannulation of the Thoracic Duct and Embolization of the Cisterna Chyli in the Treatment of Chylous Ascites

Cited by 80 publications

References 15 publications

Superselective retrograde lymphatic duct embolization for management of postoperative lymphatic leak

Superselective retrograde lymphatic duct embolization for management of postoperative lymphatic leak

Can Translational Medicine Exploit the Reported "Metastatic Inefficiency" of Lung Cancer Spreading to the Liver?

Successful Minimally Invasive Treatment of Intractable, Postoperative Chylous Ascites Via Percutaneous Lymph Vessel Embolization

Contact Info

Product

Resources

About